J. Mitra Mal Card Malaria rapid card - Pack of 50 Tests

The Advantage MAL Card is a groundbreaking immunoassay designed for the qualitative diagnosis of various Plasmodium species, including P. falciparum, P. vivax, P. malariae, P. ovale, and P. falciparum, based on the detection of pLDH antigen in human whole blood. This visual and sensitive diagnostic tool offers numerous advantages, making it a valuable asset in the early detection and diagnosis of malaria.

**Salient Features:**

- **Infection-Free Design:** The Advantage MAL Card boasts a see-through device that operates based on the pLDH antigen. It allows for the detection of malaria parasites in whole blood without the risk of infection.

- **Excellent Sensitivity & Specificity:** This immunoassay adheres to the stringent standards set by the WHO Malaria RDTs Evaluation, ensuring exceptional sensitivity and specificity in malaria diagnosis.

- **Longer Shelf Life:** The Advantage MAL Card offers a generous shelf life of 24 months when stored within a temperature range of 4-30°C, enhancing its reliability and cost-effectiveness.

- **Easy Interpretation:** Results are conveniently displayed through color bands, allowing for straightforward interpretation by healthcare professionals.

- **Rapid Results:** Within just 20 minutes, the Advantage MAL Card delivers accurate results, enabling swift decision-making in patient care.

**Specifications:**

- **Shelf Life:** 24 months at 4-30°C

- **Brand:** J.Mitra

- **Sensitivity & Specificity:** Excellent, compliant with WHO Malaria RDTs Evaluation standards

In essence, the Advantage MAL Card offers a reliable, rapid, and sensitive solution for the diagnosis of various Plasmodium species responsible for malaria infections. Its user-friendly design, exceptional accuracy, and extended shelf life make it a valuable tool in the fight against this widespread and potentially life-threatening disease. Trust in its capabilities for early and precise malaria diagnosis, ultimately contributing to improved patient care and outcomes.